[Antiviral activities of cycloheximide and its derivatives]. 2010

Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

Cycloheximide (CHX) inhibits protein synthesis in most eukaryotic cells and it is a well-known tool commonly used in biochemical research. In this paper, the antiviral spectrum of CHX against several DNA and RNA viruses have been evaluated. CHX showed strong inhibitory activities against several RNA viruses such as HIV-1, influenza viruses, coxsackie B virus, enterovirus (EV71) and several DNA viruses such as HSV and HCMV. Especially the strong inhibitory activities of CHX against coxsackie B virus and enterovirus caught our attention, since effective drugs available in clinic are limited. The SAR of CHX derivatives also has been discussed in the paper. The hydroxyl group at C-2' and carbonyl group at C-2" of CHX are essential for its antiviral activity. And modification to these groups results its derivatives' antiviral activities reduced or lost.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D004267 DNA Viruses Viruses whose nucleic acid is DNA. DNA Virus,Virus, DNA,Viruses, DNA
D004770 Enterovirus A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated "human enterovirus". Coxsackie Viruses,Coxsackieviruses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012328 RNA Viruses Viruses whose genetic material is RNA. RNA Rodent Viruses,RNA Rodent Virus,RNA Virus,Rodent Virus, RNA,Rodent Viruses, RNA,Virus, RNA,Virus, RNA Rodent,Viruses, RNA,Viruses, RNA Rodent
D029822 Enterovirus B, Human A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B. Bornholm Disease Virus,Coxsackievirus A9, Human,Echoviruses,Pleurodynia Virus,Coxsackie A9 Virus,Coxsackie B Viruses,Coxsackieviruses B,Echo Viruses,Human Coxsackievirus A9,Human Enterovirus B,Swine Vesicular Disease Virus,A9 Viruses, Coxsackie,Coxsackie A9 Viruses,Coxsackie B Virus,Disease Virus, Bornholm,Echo Virus,Echovirus,Pleurodynia Viruses,Virus, Bornholm Disease,Virus, Coxsackie A9,Virus, Coxsackie B,Viruses, Coxsackie A9

Related Publications

Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
January 2022, Journal of natural products,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
April 2019, Molecules (Basel, Switzerland),
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
October 2021, Pharmaceuticals (Basel, Switzerland),
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
November 1986, Pharmacological research communications,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
February 2012, Bioorganic & medicinal chemistry letters,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
January 2004, Arzneimittel-Forschung,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
February 1972, Biochemical pharmacology,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
January 1995, Nucleic acids symposium series,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
November 2010, Chemical & pharmaceutical bulletin,
Hui-fang Guo, and Yu-huan Li, and Pei-zhen Tao, and Hong Yi, and Shu-qin Wang, and Wei-ying He, and Jian-dong Jiang, and Zhuo-rong Li
October 1977, The Journal of general virology,
Copied contents to your clipboard!